DE2613345C3 - Verfahren zur Herstellung von 2-(2-Hydroxy-2-propyl)-l-methyl-5-nitroimidazol - Google Patents
Verfahren zur Herstellung von 2-(2-Hydroxy-2-propyl)-l-methyl-5-nitroimidazolInfo
- Publication number
- DE2613345C3 DE2613345C3 DE2613345A DE2613345A DE2613345C3 DE 2613345 C3 DE2613345 C3 DE 2613345C3 DE 2613345 A DE2613345 A DE 2613345A DE 2613345 A DE2613345 A DE 2613345A DE 2613345 C3 DE2613345 C3 DE 2613345C3
- Authority
- DE
- Germany
- Prior art keywords
- nitroimidazole
- methyl
- hydroxy
- propyl
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 10
- DTHPMNDYKOSVFR-UHFFFAOYSA-N 2-(1-methyl-5-nitroimidazol-2-yl)propan-2-ol Chemical compound CN1C([N+]([O-])=O)=CN=C1C(C)(C)O DTHPMNDYKOSVFR-UHFFFAOYSA-N 0.000 title description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 21
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 8
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- 239000001301 oxygen Substances 0.000 claims description 8
- 239000007858 starting material Substances 0.000 claims description 7
- BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 230000003647 oxidation Effects 0.000 claims description 5
- 238000007254 oxidation reaction Methods 0.000 claims description 5
- 239000012429 reaction media Substances 0.000 claims description 4
- 239000000010 aprotic solvent Substances 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 17
- 239000000243 solution Substances 0.000 description 14
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 238000003756 stirring Methods 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 7
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- NTAFJUSDNOSFFY-UHFFFAOYSA-N Ipronidazole Chemical compound CC(C)C1=NC=C([N+]([O-])=O)N1C NTAFJUSDNOSFFY-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- 239000003638 chemical reducing agent Substances 0.000 description 5
- 239000012259 ether extract Substances 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- -1 Hydroxy-2-propyl Chemical group 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- ZUNGGJHBMLMRFJ-UHFFFAOYSA-O ethoxy-hydroxy-oxophosphanium Chemical compound CCO[P+](O)=O ZUNGGJHBMLMRFJ-UHFFFAOYSA-O 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 208000004881 Amebiasis Diseases 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 206010001980 Amoebiasis Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000005448 Trichomonas Infections Diseases 0.000 description 1
- 206010044620 Trichomoniasis Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229950000107 ipronidazole Drugs 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- CYTQBVOFDCPGCX-UHFFFAOYSA-N trimethyl phosphite Chemical compound COP(OC)OC CYTQBVOFDCPGCX-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
- C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH429175 | 1975-04-04 | ||
| CH82676 | 1976-01-23 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2613345A1 DE2613345A1 (de) | 1976-10-07 |
| DE2613345B2 DE2613345B2 (de) | 1978-05-18 |
| DE2613345C3 true DE2613345C3 (de) | 1979-01-04 |
Family
ID=25685810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2613345A Expired DE2613345C3 (de) | 1975-04-04 | 1976-03-29 | Verfahren zur Herstellung von 2-(2-Hydroxy-2-propyl)-l-methyl-5-nitroimidazol |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4042597A (cg-RX-API-DMAC7.html) |
| JP (1) | JPS51127074A (cg-RX-API-DMAC7.html) |
| AR (1) | AR207279A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR7602031A (cg-RX-API-DMAC7.html) |
| DE (1) | DE2613345C3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES446674A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2306204A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2447414A (en) * | 1946-01-18 | 1948-08-17 | Monsanto Chemicals | Oxidation of isopropylbiphenyl |
| US3402205A (en) * | 1961-09-13 | 1968-09-17 | Hercules Inc | Polyperoxides |
| DE1233839B (de) * | 1965-09-08 | 1967-02-09 | Bayer Ag | Verfahren zur Herstellung von alpha,alpha,alpha',alpha'-Tetra-methyl-xylylen-dicarbon |
| US3567786A (en) * | 1967-07-31 | 1971-03-02 | Allied Chem | Oxidation of tertiary alkyl-substituted aryl compound to tertiary alcohol |
| US3794642A (en) * | 1973-01-15 | 1974-02-26 | Lilly Co Eli | Oxidation of substituted methanes to the corresponding substituted methanols |
-
1976
- 1976-01-01 AR AR262473A patent/AR207279A1/es active
- 1976-03-22 US US05/668,899 patent/US4042597A/en not_active Expired - Lifetime
- 1976-03-29 DE DE2613345A patent/DE2613345C3/de not_active Expired
- 1976-04-02 FR FR7609613A patent/FR2306204A1/fr active Granted
- 1976-04-02 ES ES446674A patent/ES446674A1/es not_active Expired
- 1976-04-02 JP JP51036186A patent/JPS51127074A/ja active Pending
- 1976-04-02 BR BR7602031A patent/BR7602031A/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES446674A1 (es) | 1977-10-16 |
| JPS51127074A (en) | 1976-11-05 |
| US4042597A (en) | 1977-08-16 |
| DE2613345A1 (de) | 1976-10-07 |
| FR2306204B1 (cg-RX-API-DMAC7.html) | 1978-11-17 |
| AR207279A1 (es) | 1976-09-22 |
| BR7602031A (pt) | 1976-10-05 |
| DE2613345B2 (de) | 1978-05-18 |
| FR2306204A1 (fr) | 1976-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2527937A1 (de) | Benzcycloamidderivate und verfahren zu ihrer herstellung sowie pharmazeutische mittel, worin sie enthalten sind | |
| DE2222491C3 (de) | Steroid-21-salpetersäureester der Pregnanreihe, solche enthaltende Arzneimittel und Verfahren zur Herstellung derselben | |
| DE1518333C3 (de) | N,N-substituierte 4-Methylsulfonyl-2,6-dinitroaniline, Verfahren zu ihrer Herstellung und deren Verwendung | |
| DE3103372A1 (de) | Neue indanyl-derivate, ihre herstellung und verwendung | |
| DE2613345C3 (de) | Verfahren zur Herstellung von 2-(2-Hydroxy-2-propyl)-l-methyl-5-nitroimidazol | |
| DE1468311C3 (de) | 6-Chlor-4,6-pregnadien-3beta-17 alpha-diol-20-on-17-acetat-3methyläther sowie Verfahren zu dessen Herstellung und diesen enthaltende pharmazeutische Zubereitungen | |
| CH642615A5 (de) | Diphenylaether und verfahren zu deren herstellung. | |
| DE69003616T2 (de) | Diarylcycloalkanether. | |
| DE3109281C2 (de) | Verfahren zur Herstellung von 7α-Acylthio-4-en-3-oxosteroiden | |
| DD160418A1 (de) | Verfahren zur herstellung von 17alpha-substituierten gona-4,9-dienen | |
| DE2016467C3 (de) | Verfahren zur Herstellung von 1 -Hydroxy-6-nieder-alkoxy-phenazin-5,10-dioxiden | |
| DE2917178C2 (cg-RX-API-DMAC7.html) | ||
| DE2039466C3 (de) | Dioxocyclohexancaibonsäureanilide und -thioanilide und Verfahren zu ihrer Herstellung | |
| EP0029117B1 (de) | 10-Bromsandwicin und 10-Bromisosandwicin sowie deren Säureadditionssalze mit pharmakoloyisch annehmbaren Säuren, Verfahren zu deren Herstellung und deren Verwendung | |
| DE1768161C (de) | Äther des 1 a, 2 a-Methylen-19-nor-testosterons und seiner 18- Alkylhomologen, Verfahren zu ihrer Herstellung, diese enthaltende Arzneimittel sowie entsprechende S a-östran-Zwischenprodukte | |
| DE2757459A1 (de) | Benzoylphenoxyessigsaeure-derivate | |
| DE101778C (cg-RX-API-DMAC7.html) | ||
| DE1593407C3 (de) | 17beta-Hydroxy-2-oxaöstra-4,9(10)dien-3-on sowie Verfahren zur Herstellung dieser Verbindung | |
| EP0614890A2 (de) | Gegebenenfalls 2-substituierte 5-Chlorimidazole | |
| AT224116B (de) | Verfahren zur Herstellung von neuen, 4-substituierten 1,2-Diaryl-3,5-dioxo-pyrazolidinen | |
| DE1793578C3 (de) | Thionosalicylsäureanilide und Verfahren zu ihrer Herstellung. Ausscheidung aus: 1568522 | |
| DE3247215A1 (de) | Fluorhaltige biphenylverbindung und verfahren zu ihrer herstellung | |
| AT381938B (de) | Verfahren zur herstellung von neuen spirobenzofuranonverbindungen | |
| AT246732B (de) | Verfahren zur Herstellung von neuen Camphersulfonaten | |
| DE2366559C2 (de) | 1-substituierte 3-Aminopyrazolone-(5) sowie deren Verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| EHJ | Ceased/non-payment of the annual fee |